CABR Stock Analysis: Buy, Sell, or Hold?
$1.20
0.07 (6.19%)
▲
5d:
+0.0%
30d:
+22.44%
90d:
+43.88%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 30, 2026
13d
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CABR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: CABR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $1.20, which is considered slightly high relative to its 30-day fair value range of $0.95 to $1.22.
Technical Outlook: Technically, CABR is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.34. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CABR is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.34. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.95 -
$1.22
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.2%)
Trading Range Analysis
30-Day Trading Range
$0.95 -
$1.22
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.34
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: June 15, 2026 8:24 PM ET
Data refreshes hourly during market hours. Next update: 9:24 PM
Data refreshes hourly during market hours. Next update: 9:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 58 HOLD |